Beijing Centergate Technologies Holding Co Ltd000931
▲ ポジティブ技術関連度
Marketing authorization application accepted for a new drug, trazodone hydrochloride extended-release tablets, indicating progress in product pipeline.
銘柄への影響 1
その他
Beijing Centergate Technologies Holding Co Ltdテーマインパクト
カバレッジ外企業 1
北京华素制药股份有限公司非上場▲ ポジティブ
技術関連度
Subsidiary Beijing Huasu Pharmaceutical's drug application accepted, directly advancing its product development.